What disease does osimertinib/osimertinib treat?

Osimertinib/Osimertinib (Osimertinib) is a targeted therapy drug mainly used to treat advanced non-small cell lung cancer (NSCLC), especially EGFR (epidermal growth factor receptor) mutation-positive NSCLC patients. EGFRMutation is a common lung cancer mutation that is associated with tumor growth, spread, and drug resistance. Osimertinib/Osimertinib blocks the growth signaling of tumor cells by inhibiting EGFR kinase activity, thereby inhibiting the growth and spread of tumors. Compared with traditional chemotherapy drugs, Osimertinib/Osimertinib has higher selectivity and lower toxic side effects. It can significantly extend the progression-free survival and overall survival of patients, and improve the treatment effect and quality of life. Therefore, Osimertinib/Osimertinib has become the first-line treatment for patients with EGFR mutation-positive NSCLC and has brought new treatment hope to these patients.